These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Immunologic tumor diagnosis]. Schmolke B Z Lymphol; 1990 Dec; 14(2):58-61. PubMed ID: 2087871 [TBL] [Abstract][Full Text] [Related]
5. New developments in imaging and functional biomarker technology for the assessment and management of cancer patients. Hall NC; Zhang J; Povoski SP; Martin EW; Knopp MV Expert Rev Med Devices; 2009 Jul; 6(4):347-51. PubMed ID: 19572788 [No Abstract] [Full Text] [Related]
6. [Future prospects for the use of tumor markers]. Grunicke H Wien Klin Wochenschr; 1989 Jul; 101(14):472-5. PubMed ID: 2672607 [TBL] [Abstract][Full Text] [Related]
7. Expecting the unexpected--the continued need for vigilance in tumour marker assays. Sturgeon C Ann Clin Biochem; 2006 Jul; 43(Pt 4):247-8. PubMed ID: 16824272 [No Abstract] [Full Text] [Related]
8. [Glycosphingolipids as tumor markers]. Lenícková L; Smíd F Cas Lek Cesk; 1997 Nov; 136(21):655-61. PubMed ID: 9490212 [TBL] [Abstract][Full Text] [Related]
9. [Antigenic markers in the cytological diagnosis of human malignant neoplasms]. Frank GA; Pugachev KK; Shabalova IP; Shimbireva IB Arkh Patol; 1990; 52(8):70-4. PubMed ID: 2281989 [TBL] [Abstract][Full Text] [Related]
10. Serum tumour markers in clinical practice. Some general aspects. Kvinnsland S Scand J Clin Lab Invest Suppl; 1991; 206():6-11. PubMed ID: 1947761 [TBL] [Abstract][Full Text] [Related]
12. Use of tumour markers in cancer diagnosis and treatment. Higgins C Nurs Times; 1996 Apr 17-23; 92(16):36-7. PubMed ID: 8710591 [TBL] [Abstract][Full Text] [Related]
13. [The development of immunoscintigraphy into a routine method]. Pateisky N Wien Klin Wochenschr; 1990 Aug; 102(15):424-6. PubMed ID: 2205987 [TBL] [Abstract][Full Text] [Related]
14. Protein chips and nanomaterials for application in tumor marker immunoassays. Chen H; Jiang C; Yu C; Zhang S; Liu B; Kong J Biosens Bioelectron; 2009 Aug; 24(12):3399-411. PubMed ID: 19398322 [TBL] [Abstract][Full Text] [Related]
16. Tumour markers: their use and misuse by clinicians. McGinley PJ; Kilpatrick ES Ann Clin Biochem; 2003 Nov; 40(Pt 6):643-7. PubMed ID: 14629802 [TBL] [Abstract][Full Text] [Related]
17. Tumour markers--an update. Proceedings from the first meeting on tumour markers. Trondheim, 24-25 May 1991. Scand J Clin Lab Invest Suppl; 1991; 206():5-105. PubMed ID: 1947759 [No Abstract] [Full Text] [Related]
18. [Tumour markers in malignant diseases]. Ottó S; Ferencz A Magy Onkol; 2004; 48(1):13-20. PubMed ID: 15105891 [TBL] [Abstract][Full Text] [Related]
20. Proceedings: The MEM test in the diagnosis and prognosis of malignant disease. Pritchard JA Br J Radiol; 1976 Mar; 49(579):290. PubMed ID: 1276610 [No Abstract] [Full Text] [Related] [Next] [New Search]